Literature DB >> 3029138

Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines.

G Bepler, G Jaques, K Neumann, G Aumüller, C Gropp, K Havemann.   

Abstract

Cell lines from SCLC were established with a success rate of 43% from different metastatic sites of treated and untreated patients. All 6 SCLC cell lines grew as floating cell aggregates without substrate adherence. The degree of aggregation ranged from very tight spheroids to very loose sheets and chains. This gross morphological property showed a striking correlation to the PDT, with short PDTs in loose growing cell lines and long PDTs in tight growing cell lines. Cell size and nuclear features, i.e., chromatin pattern and nucleolar prominence, also seemed to correlate with the PDT and gross morphology. All SCLC cell lines had dense core granules by electron microscopical examination. Several different serum-free and serum-supplemented growth media were tested for their feasibility in establishing and permanently growing SCLC. Serum-free SIT medium and SIT2.5 medium provided the best results in liquid culture. For semisolid SCLC cultivation, R 10 medium was superior to all other media tested. These cell lines are currently under intensive biochemical, molecular biological, and cytogenetical investigation in different laboratories and thus provide a tool for studying the biology of lung cancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029138     DOI: 10.1007/BF00389964

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

1.  A new in vitro cell line established from human large cell variant of oat cell lung cancer.

Authors:  E R Fisher; J D Paulson
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  A new floating cell line derived from human pulmonary carcinoma of oat cell type.

Authors:  S Oboshi; S Tsugawa; T Seido; Y Shimosato; T Koide
Journal:  Gan       Date:  1971-12

3.  Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid.

Authors:  K G Bensch; B Corrin; R Pariente; H Spencer
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

4.  Lung cancer in women. Lahey Clinic experience, 1957-1980.

Authors:  J L Andrews; S Bloom; K Balogh; J F Beamis
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860

5.  Isolation and characterization of a hormone-producing cell line from human small cell anaplastic carcinoma of the lung.

Authors:  O S Pettengill; C S Faulkner; D H Wurster-Hill; L H Maurer; G D Sorenson; A G Robinson; E A Zimmerman
Journal:  J Natl Cancer Inst       Date:  1977-03       Impact factor: 13.506

6.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

Authors:  J Whang-Peng; C S Kao-Shan; E C Lee; P A Bunn; D N Carney; A F Gazdar; J D Minna
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

7.  Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung.

Authors:  J Bergh; K Nilsson; R Ekman; B Giovanella
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1985-05

8.  Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.

Authors:  D N Carney; P A Bunn; A F Gazdar; J A Pagan; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung.

Authors:  O S Pettengill; G D Sorenson; D H Wurster-Hill; T J Curphey; W W Noll; C C Cate; L H Maurer
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

10.  Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).

Authors:  H Baillie-Johnson; P R Twentyman; N E Fox; G A Walls; P Workman; J V Watson; N Johnson; J G Reeve; N M Bleehen
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

View more
  29 in total

Review 1.  Serum-free culture of carcinoma cell lines.

Authors:  P Collodi; C Rawson; D Barnes
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

2.  Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.

Authors:  Terri B Hunter; Neil J Manimala; Kimberly A Luddy; Tracy Catlin; Scott J Antonia
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

3.  Immunotargeting of human small cell lung cancer xenografts in athymic mice using a monoclonal antibody (RNL-1) against a neuroendocrine-related antigen.

Authors:  E P Mijnheere; O C Boerman; J L Broers; M Klein Rot; G P Vooijs; F C Ramaekers
Journal:  Br J Cancer Suppl       Date:  1991-06

4.  Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines.

Authors:  P B Jensen; H Roed; L Vindeløv; I J Christensen; H H Hansen
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

Review 5.  Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.

Authors:  Lisheng Ge; Neil T Hoa; Zechariah Wilson; Gabriel Arismendi-Morillo; Xiao-Tang Kong; Rajeev B Tajhya; Christine Beeton; Martin R Jadus
Journal:  Int Immunopharmacol       Date:  2014-07-12       Impact factor: 4.932

6.  Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma.

Authors:  Lothar Graff; Mónica Frungieri; Robert Zanner; Agnes Pohlinger; Christian Prinz; Manfred Gratzl
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

7.  Tetanus toxin as a marker for small-cell lung cancer cell lines.

Authors:  J Heymanns; K Neumann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

8.  Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.

Authors:  Neil T Hoa; Lisheng Ge; Rajeev B Tajhya; Christine Beeton; Andrew N Cornforth; Amir Abolhoda; Nils Lambrecht; Maria DaCosta-Iyer; Yi Ouyang; Anthony P Mai; Erin Hong; Judy Shon; Michelle J Hickey; Kate L Erickson; Carol A Kruse; Martin R Jadus
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

9.  Expression of vitamin D receptor in lung cancer.

Authors:  U Kaiser; M Schilli; B Wegmann; P Barth; S Wedel; J Hofmann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

10.  Nuclear A-type lamins are differentially expressed in human lung cancer subtypes.

Authors:  J L Broers; Y Raymond; M K Rot; H Kuijpers; S S Wagenaar; F C Ramaekers
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.